We are live on ! Find out more
FCOMV

Foresite Capital Opportunity Management V Portfolio holdings

AUM $33.3M
1-Year Est. Return 47.04%
This Fund
S&P 500
This Quarter Est. Return
+35.74%
1 Year Est. Return
-47.04%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$149M
AUM Growth
–
Cap. Flow
+$124M
Cap. Flow %
83.06%
Top 10 Hldgs %
100%
Holding
9
New
9
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
+$60.8M
2
HLTH
Cue Health Inc. Common Stock
HLTH
+$16.8M
3
QSI icon
Quantum-Si Incorporated
QSI
+$12M
4
IRON icon
Disc Medicine
IRON
+$7.96M
5
CGEM icon
Cullinan Oncology
CGEM
+$7.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRDS
1
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$85.6M 57.37%
+5,227,307
New +$60.8M
HLTH
2
DELISTED
Cue Health Inc. Common Stock
HLTH
$20.5M 13.73%
+1,527,103
New +$16.8M
QSI icon
3
Quantum-Si Incorporated
QSI
$171M
$12.6M 8.43%
+1,598,125
New +$12M
IRON icon
4
Disc Medicine
IRON
$3.07B
$7.09M 4.75%
+81,171
New +$7.96M
THRX
5
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$5.95M 3.99%
+468,820
New +$7.08M
CGEM icon
6
Cullinan Oncology
CGEM
$1.4B
$5.88M 3.94%
+381,002
New +$7.6M
KNTE
7
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$5.17M 3.46%
+291,667
New +$6.15M
CMPX icon
8
Compass Therapeutics
CMPX
$432M
$3.49M 2.34%
+1,100,000
New +$3.65M
ACET icon
9
Adicet Bio
ACET
$84.8M
$2.97M 1.99%
+10,625
New +$1.82M

Similar funds

SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return

Foresite Capital Opportunity Management V's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Foresite Capital Opportunity Management V, which disclosed 9 positions worth $149M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Pardes Biosciences, Inc. Common Stock: 5,227,307 shares worth $85.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Foresite Capital Opportunity Management V's largest Q4 2021 buy was Pardes Biosciences, Inc. Common Stock: 5,227,307 shares worth $85.6M.
  • Foresite Capital Opportunity Management V's ten largest holdings make up 100% of its $149M portfolio in Q4 2021.
  • Foresite Capital Opportunity Management V disclosed 9 positions in Q4 2021, its first 13F filing on record.

Based on Foresite Capital Opportunity Management V's 13F filing for Q4 2021, filed 11 Feb 2022.